Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A L Epstein

Showing results (61-70 of 130) with videos related to

Pageof 13
Sort By:
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|September 1, 1989
LN-6: a monoclonal antibody to vimentin expressed in non-hematopoietic mesenchymal cells and derived tumors and reactive in B5-fixed, paraffin-embedded tissuesE Stathopoulos, G S Naeve, C R Taylor, et al.
International Journal of Cancer|April 15, 1977
Chromosome 14 translocation in African and North American Burkitt's lymphoma;B Kaiser-McCaw, A L Epstein, H S Kaplan, et al.
Journal of Immunoassay|January 1, 1991
Cell based radioimmunoassays to quantitate the immunoreactivity of TNT monoclonal antibodies directed against intracellular antigensS A Gaffar, F M Chen, C Liu, et al.
Journal of Cellular Biochemistry|December 1, 1995
Nuclear domain 10 (ND10) associated proteins are also present in nuclear bodies and redistribute to hundreds of nuclear sites after stressG G Maul, E Yu, A M Ishov, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1991
Synthesis and preliminary evaluation of a new chelate N2S4 for use in labeling proteins with metallic radionuclidesA Najafi, M M Alauddin, M E Siegel, et al.
Hybridoma and Hybridomics|February 13, 2002
Characterization of a phage display-derived human monoclonal antibody (NHS76) counterpart to chimeric TNT-1 directed against necrotic regions of solid tumorsJ Sharifi, L A Khawli, P Hu, et al.
International Journal of Cancer|June 15, 1987
Monoclonal antibody DLC-48: an effective reagent for use in the depletion of malignant lymphoma from human bone marrowJ N Winter, R J Marder, J A Radosevich, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1984
Two new monoclonal antibodies (LN-1, LN-2) reactive in B5 formalin-fixed, paraffin-embedded tissues with follicular center and mantle zone human B lymphocytes and derived tumorsA L Epstein, R J Marder, J N Winter, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 1, 1996
Improved tumor localization and radioimaging with chemically modified monoclonal antibodiesL A Khawli, M S Glasky, M M Alauddin, et al.
Hybridoma|December 1, 1993
Immunologic and biochemical analysis of TNT-1 and TNT-2 monoclonal antibody binding to histonesG K Miller, G S Naeve, S A Gaffar, et al.
Pageof 13

Showing results (61-70 of 130) with videos related to

Sort By:
Pageof 13
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|September 1, 1989
LN-6: a monoclonal antibody to vimentin expressed in non-hematopoietic mesenchymal cells and derived tumors and reactive in B5-fixed, paraffin-embedded tissuesE Stathopoulos, G S Naeve, C R Taylor, et al.
International Journal of Cancer|April 15, 1977
Chromosome 14 translocation in African and North American Burkitt's lymphoma;B Kaiser-McCaw, A L Epstein, H S Kaplan, et al.
Journal of Immunoassay|January 1, 1991
Cell based radioimmunoassays to quantitate the immunoreactivity of TNT monoclonal antibodies directed against intracellular antigensS A Gaffar, F M Chen, C Liu, et al.
Journal of Cellular Biochemistry|December 1, 1995
Nuclear domain 10 (ND10) associated proteins are also present in nuclear bodies and redistribute to hundreds of nuclear sites after stressG G Maul, E Yu, A M Ishov, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1991
Synthesis and preliminary evaluation of a new chelate N2S4 for use in labeling proteins with metallic radionuclidesA Najafi, M M Alauddin, M E Siegel, et al.
Hybridoma and Hybridomics|February 13, 2002
Characterization of a phage display-derived human monoclonal antibody (NHS76) counterpart to chimeric TNT-1 directed against necrotic regions of solid tumorsJ Sharifi, L A Khawli, P Hu, et al.
International Journal of Cancer|June 15, 1987
Monoclonal antibody DLC-48: an effective reagent for use in the depletion of malignant lymphoma from human bone marrowJ N Winter, R J Marder, J A Radosevich, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1984
Two new monoclonal antibodies (LN-1, LN-2) reactive in B5 formalin-fixed, paraffin-embedded tissues with follicular center and mantle zone human B lymphocytes and derived tumorsA L Epstein, R J Marder, J N Winter, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 1, 1996
Improved tumor localization and radioimaging with chemically modified monoclonal antibodiesL A Khawli, M S Glasky, M M Alauddin, et al.
Hybridoma|December 1, 1993
Immunologic and biochemical analysis of TNT-1 and TNT-2 monoclonal antibody binding to histonesG K Miller, G S Naeve, S A Gaffar, et al.
Pageof 13